Metraipolis › archive › dc_11e2d1889efb

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss — Europe PMC PMID:41291905

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41291905
DOI
10.1186/s13195-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-08T06:47:43.304Z
SHA-256 of the archived text
2728bcc4e6d75b6b73dcd613589c6ef09e21b3bb41b044a8ae73badc88a06c15
Stable URL of this page
https://metraipolis.com/documento/dc_11e2d1889efb

How to cite

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss — Europe PMC PMID:41291905 — Europe PMC (en), https://europepmc.org/article/MED/41291905 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11e2d1889efb (Metraipolis archive dc_11e2d1889efb, sha256 2728bcc4e6d75b6b73dcd613589c6ef09e21b3bb41b044a8ae73badc88a06c15)
BibTeX
@misc{dc11e2d1889efb,
  title = {Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss — Europe PMC PMID:41291905},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41291905},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11e2d1889efb; sha256 2728bcc4e6d75b6b73dcd613589c6ef09e21b3bb41b044a8ae73badc88a06c15},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41291905. Agents can read the archived copy with the MCP tool read_document.